These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24245425)

  • 41. Breast screening is beneficial, panel concludes, but women need to know about harms.
    Hawkes N
    BMJ; 2012 Oct; 345():e7330. PubMed ID: 23112065
    [No Abstract]   [Full Text] [Related]  

  • 42. The uncritical use of high-tech medical imaging.
    Hillman BJ; Goldsmith JC
    N Engl J Med; 2010 Jul; 363(1):4-6. PubMed ID: 20573920
    [No Abstract]   [Full Text] [Related]  

  • 43. The American difference in health care costs: is there a problem? Is medical necessity the solution?
    Jost TS
    Spec Law Dig Health Care Law; 1999 Dec; (249):9-34. PubMed ID: 10747456
    [No Abstract]   [Full Text] [Related]  

  • 44. Save your life: cancer screening is oversold. Know the tests to get--and those to skip.
    Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197
    [No Abstract]   [Full Text] [Related]  

  • 45. How much care is good for us?
    Volpintesta EJ
    Conn Med; 2000 Jun; 64(6):371-2. PubMed ID: 10909203
    [No Abstract]   [Full Text] [Related]  

  • 46. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 47. Reports show the power of comparative analysis technology.
    Capitation Rates Data; 1999 Feb; 4(2):22-4. PubMed ID: 10346248
    [No Abstract]   [Full Text] [Related]  

  • 48. Stop me before I kill again.
    Friedman E
    Healthc Forum J; 1998; 41(6):8, 10-2. PubMed ID: 10346621
    [No Abstract]   [Full Text] [Related]  

  • 49. Investigation momentum: the relentless pursuit to resolve uncertainty.
    Sah S; Elias P; Ariely D
    JAMA Intern Med; 2013 May; 173(10):932-3. PubMed ID: 23588200
    [No Abstract]   [Full Text] [Related]  

  • 50. Screening: when things go wrong.
    Dickinson JA; Pimlott N; Grad R; Singh H; Szafran O; Wilson BJ; Groulx S; Thériault G; Bell NR
    Can Fam Physician; 2018 Jul; 64(7):502-508. PubMed ID: 30002025
    [No Abstract]   [Full Text] [Related]  

  • 51. COST IMPLICATIONS OF UNNECESSARY COAGULATION SCREENS IN SURGICAL PATIENTS--A MULTI-CENTRE STUDY.
    Spence RA; McCusker D; Loughlin PM; Weir CD
    Ulster Med J; 2015 Oct; 84(3):189. PubMed ID: 27032113
    [No Abstract]   [Full Text] [Related]  

  • 52. Getting your doctor to listen. How to avoid having unnecessary tests--and getting the wrong diagnosis.
    Harv Womens Health Watch; 2013 Jun; 20(10):6. PubMed ID: 23977707
    [No Abstract]   [Full Text] [Related]  

  • 53. Screening is not worth the pain or the money.
    Greer G
    Nurs Times; 2000 Jun 8-14; 96(23):8. PubMed ID: 11963082
    [No Abstract]   [Full Text] [Related]  

  • 54. Early detection and control of cancer in clinical practice.
    Bergner M; Allison CJ; Diehr P; Ford LG; Feigl P
    Arch Intern Med; 1990 Feb; 150(2):431-6. PubMed ID: 2302018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-cost, office-based, screening colonoscopy.
    Overholt BF
    Am J Gastroenterol; 1995 Apr; 90(4):671-2. PubMed ID: 7717341
    [No Abstract]   [Full Text] [Related]  

  • 56. Are some screening tests doing more harm than good?
    Lin KW; Duane MR
    Am Fam Physician; 2007 Aug; 76(3):351-2. PubMed ID: 17708134
    [No Abstract]   [Full Text] [Related]  

  • 57. Early diagnosis of melanoma: what is the impact of dermoscopy?
    Argenziano G; Albertini G; Castagnetti F; De Pace B; Di Lernia V; Longo C; Pellacani G; Piana S; Ricci C; Zalaudek I
    Dermatol Ther; 2012; 25(5):403-9. PubMed ID: 23046019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The diagnostic value of medical examinations and their use: external validity].
    Ben Hamida A; M'Rad S; Ben Hamida L; H'Sairi M; Zouari B; Nacef T
    Tunis Med; 1992; 70(6-7):321-4. PubMed ID: 1448854
    [No Abstract]   [Full Text] [Related]  

  • 59. Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.
    Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Moul JW
    BJU Int; 2011 Jul; 108(1):44-8. PubMed ID: 21050357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PSA screening isn’t “nonsense”—it saved my life.
    Orwig S
    J Fam Pract; 2011 Aug; 60(8):453. PubMed ID: 21928548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.